Randall Weisenburger - Executive Vice President and Chief Financial Officer
Analyst
As John noted we are very pleased with the strong performance of our agencies. Revenue growth in Q3 increased $251 million to $2.77 billion that was an increase of 10%. For the nine months revenue increased 8.2% to $8.16 billion. Operating income for the quarter was $307.4 million, up 12% that’s an operating margin with about 11.1%, which was up about 20 basis points from last year. For the nine months operating income increased 10.5% to just over $1 billion and the operating margin was 12.4%, which was up about 30 basis points from last year. There are a couple of anomalies in our numbers this quarter worth noting that impact operating income, taxes, and net income, I will try to cover all three of those topics now. First, during the quarter we disposed off the US based healthcare business and several small businesses. With respect to the healthcare business, after deducting goodwill to transaction resulted in a small pre-tax loss. However, for tax purposes the pre-tax gain cannot be reduced by the goodwill amount, because the goodwill deducted for book purposes could not be deducted on the tax return, we will require to record tax expense for book purposes, resulting in the high book tax rate for this transaction. The second event in the quarter was the favorable resolution of uncertainties related to changes in certain foreign tax laws that occurred last year. As a result in the quarter there was a one time true up tax benefit. In the aggregate, the impact of these items in the quarter was a decrease in profit before tax of a half a million dollars, and a decrease in tax expense or a tax benefit of $1.8 million resulting in an increase in net income of $1.3 million. Adjusting for these items our year over year operating income in the quarter increased 12.2% and our operating margin increased from 10.9% to 11.1% or about 20 basis points. Moving down to P&L, net interest expense for the quarter was $26.7 million that was an increase of $10.4 million versus Q3 last year. And for the nine months net interest was $67.4 million up $24.7 million compared to last year. The year over year increase is due to primarily to our issuance of a ten-year fixed rate note at the end of Q1, if you recall that was a billion dollar issue with an annual interest rate of about 6.1% or about $15 million a quarter. This increase in interest was somewhat offset by reduction in other debt as we used some of the proceeds of that financing to pay down our outstanding bank loan, and part of it converts. On the tax front, our reported tax rate was 33.1% after adjusting for the unique items that I mentioned earlier. Our operating tax rate for the quarter and for the nine months were pretty much unchanged at 33.7%. Net income for the quarter increased 9.5% to $177.1 million brining the year to date net income to $586.8 million that was an increase of 9.1%. Fully diluted earnings per share for the quarter increased 15.6% to a $4 per share again adjusted for the net impact of the unique items I mentioned, EPS was a $3 or about 14.4% increase. For the nine months diluted earnings per share increased 14.6% to $3.38 per share. Analyzing our revenue performance FX was positive 1.9% or $47.9 million in the quarter. However, year-to-date it remains marginally negative at 0.002% or about $13.4 million. If you recall in Q1 FX was negative of about 2%, in Q2 it was neutral and now in Q3 it’s a positive 1.9%. If rates stay where they are FX should be positive about 1.5% in Q4. Acquisition growth net of dispositions was marginally negative in the quarter reducing revenue by $4.4 million or about one tenth of 1%. This decrease is primarily the result of the disposition of the previously mentioned healthcare business. For the year however, acquisitions have added about $29.2 million or four-tenths of point of our revenue. And organic growth again was very strong this quarter accelerating to 8.2% and accounting for about $207.9 million of our revenue growth. For the nine months organic growth was increased to 8% adding about $603.2 millions to our revenue. As for our mix of business in the quarter, traditional media advertising accounted for 41.4% of our revenue and marketing services 58.6%, for the first nine months the ratios were 42.6 and 57.4 for marketing services. As for their respective growth rates advertising grew 6.5% in the quarter and 5.8% year-to-date and marketing services which has been driven by the continuing strong performance of our CRM business and now resurgence in the PR sector grew 12.6% in the quarter, bringing the nine-month growth rate up to 10.1. Breaking down our marketing services revenue for the quarter CRM was approximately 36.9%, PR 10.5% and specialty communications 11.2%, as for their respective total growth rates CRM accelerated to 16.7% in the quarter, public relations as I mentioned picked up significantly growing 13.1% and specialty communications which would adversely impacted by the healthcare business disposition we discussed increased four tenth of 1%. Adjusting for the sale that I mentioned specialty communications would have grown about 7%. Our geographic mix of business in the quarter was 55.5% US, 45.5% international. In the US total revenue growth for the quarter was $111.9 million or 7.8%. Acquisitions were effectively neutral; I think they ended up with the net negative $100,000 in the quarter. Organic growth remains strong and steady at about 7.8%, adding about $112 million for revenue. The international front revenue increased by $139.5 million or 12.7%, acquisition growth was a net negative $4.3 million, FX had a positive impact of $47.9 million and organic growth due to largely the strong performances in the UK, Germany, France and China with $95.5 million or about 8.8%. Cash flow in the quarter and year-to-date has been very strong and our cash management programs have continued to perform very well. As we believe everyone already knows our primary source of cash flow is net income, adjusted for basic non-cash charges which for us are primarily stock based compensation charges and they relate to tax benefits as well as depreciation and amortization. As for our primary uses of cash, there are four dividends, which are currently running at $0.25 per share per quarter have totaled $133.1 million year-to-date. Capital expenditures totaled approximately $119.5 million. Acquisitions, net of dispositions and asset sales, including earned out payments on prior acquisitions have totaled approximately $178 million. And share repurchases which in the quarter totaled $123.5 million bringing our year-to-date total to about $1.1 billion. We also received $167 million of proceeds from option exercises and stock sold under our employee stock purchase plan resulting in net repurchases year-to-date of $916 million. As a result of our net repurchase activity year-to-date, our diluted share cap for the quarter was about 170.9 million shares and for the nine months 173.8 million. As a result of the strong cash management performance this year we finished the quarter with a net debt position of approximately $2.2 billion that’s roughly flat year-over-year. And we had available liquidity of about $3.3 billion. Now I’ll ask the operator to open the call for questions.
Troy Mastin - William Blair & Company: Good morning, couple of quick questions. First you had mentioned China as having yielded incredible results, I wonder if you could maybe quantify that a little bit more of course in terms of size and growth rate and maybe any other anecdotes you might be willing to share.